Ultimovacs ASA (ULTI.OL)
NOK 2.05
(0.0%)
NOK 2.05
(0.0%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | -5.50 NOK | -28.21% |
| 2022 | -4.29 NOK | 16.7% |
| 2021 | -5.15 NOK | -33.42% |
| 2020 | -3.86 NOK | -58.2% |
| 2019 | -2.44 NOK | 27.38% |
| 2018 | -3.36 NOK | -60.77% |
| 2017 | -2.09 NOK | -12.37% |
| 2016 | -1.86 NOK | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q1 | -0.66 NOK | 59.51% |
| 2024 Q2 | -1.30 NOK | -96.97% |
| 2023 Q1 | -0.51 NOK | 67.31% |
| 2023 Q4 | -1.63 NOK | -0.62% |
| 2023 Q3 | -1.62 NOK | -28.57% |
| 2023 Q2 | -1.26 NOK | -147.06% |
| 2023 FY | - NOK | -28.21% |
| 2022 Q2 | -0.27 NOK | 77.69% |
| 2022 Q1 | -1.21 NOK | 24.38% |
| 2022 FY | - NOK | 16.7% |
| 2022 Q4 | -1.56 NOK | -64.21% |
| 2022 Q3 | -0.95 NOK | -251.85% |
| 2021 Q1 | -1.14 NOK | -65.22% |
| 2021 FY | - NOK | -33.42% |
| 2021 Q4 | -1.60 NOK | -15.94% |
| 2021 Q2 | -1.05 NOK | 7.89% |
| 2021 Q3 | -1.38 NOK | -31.43% |
| 2020 Q4 | -0.69 NOK | 27.37% |
| 2020 Q1 | -1.06 NOK | -21.84% |
| 2020 Q2 | -1.15 NOK | -8.49% |
| 2020 Q3 | -0.95 NOK | 17.39% |
| 2020 FY | - NOK | -58.2% |
| 2019 Q1 | -0.52 NOK | 26.76% |
| 2019 FY | - NOK | 27.38% |
| 2019 Q4 | -0.87 NOK | -61.11% |
| 2019 Q3 | -0.54 NOK | -200.0% |
| 2019 Q2 | -0.18 NOK | 65.38% |
| 2018 Q1 | -0.68 NOK | -47.83% |
| 2018 FY | - NOK | -60.77% |
| 2018 Q4 | -0.71 NOK | 31.73% |
| 2018 Q3 | -1.04 NOK | -14.29% |
| 2018 Q2 | -0.91 NOK | -33.82% |
| 2017 Q1 | -0.55 NOK | 0.0% |
| 2017 Q2 | -0.48 NOK | 12.73% |
| 2017 Q4 | -0.46 NOK | 11.54% |
| 2017 Q3 | -0.52 NOK | -8.33% |
| 2017 FY | - NOK | -12.37% |
| 2016 FY | - NOK | 0.0% |
| Name | Eps | Eps Difference |
|---|---|---|
| Arctic Bioscience AS | -1.79 NOK | -207.263% |
| Aqua Bio Technology ASA | -0.99 NOK | -455.556% |
| ArcticZymes Technologies ASA | 0.38 NOK | 1547.368% |
| BerGenBio ASA | -13.30 NOK | 58.647% |
| Hofseth BioCare ASA | -0.27 NOK | -1937.037% |
| PCI Biotech Holding ASA | -0.54 NOK | -918.519% |
| Thor Medical ASA | -0.03 NOK | -17195.597% |